Phase II feasibility study of sequential couplets of Cisplatin/Topotecan followed by paclitaxel/cisplatin as primary treatment for advanced epithelial ovarian cancer: a National Cancer Institute of Canada Clinical Trials Group Study (Q73300381)
Jump to navigation
Jump to search
scientific article published on 01 December 2000
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II feasibility study of sequential couplets of Cisplatin/Topotecan followed by paclitaxel/cisplatin as primary treatment for advanced epithelial ovarian cancer: a National Cancer Institute of Canada Clinical Trials Group Study |
scientific article published on 01 December 2000 |
Statements
Phase II feasibility study of sequential couplets of Cisplatin/Topotecan followed by paclitaxel/cisplatin as primary treatment for advanced epithelial ovarian cancer: a National Cancer Institute of Canada Clinical Trials Group Study (English)
P Hoskins
E Eisenhauer
J Dubuc-Lissoir
B Fisher
R Grimshaw
A Oza
M Plante
G Stuart